Form 4: Humana Executive's Routine Stock Transactions

Humana's President of Insurance, George Renaudin II, reported recent acquisitions and dispositions of company stock related to RSU vesting and tax obligations.

Summary

• George Renaudin II, President, Insurance at Humana Inc., reported transactions on December 15, 2025, related to his beneficial ownership of Humana common stock and derivative securities.
• Acquired 2,106 shares of Humana Common stock at a price of $0, likely due to the vesting of restricted stock units.
• Disposed of 830 shares of Humana Common stock at a price of $270.155 to cover tax liabilities associated with restricted stock vesting.
• Acquired an additional 360 shares of Humana Common stock at a price of $0, also likely from restricted stock unit vesting.
• Disposed of 142 shares of Humana Common stock at a price of $270.155 to cover further tax liabilities related to restricted stock vesting.
• Following these transactions, direct beneficial ownership of Humana Common stock stands at 15,459 shares, which includes 9,059 restricted stock units.
• Indirectly owns 525 shares in the Humana Retirement Savings Plan and 172 Phantom Stock Units in the Humana Retirement Equalization Plan.
• Holds options to purchase 4,162 shares with an exercise price of $510.2425, granted on February 24, 2023, vesting in three annual increments from February 24, 2024, to February 24, 2026, and expiring on February 24, 2030.
• Holds options to purchase 6,966 shares with an exercise price of $367.21, granted on February 21, 2024, vesting in three annual increments from February 21, 2025, to February 21, 2027, and expiring on February 21, 2031.

Sentiment

Score: 5

Explanation: The filing details routine insider transactions related to executive compensation, specifically the vesting of restricted stock units and the subsequent sale of shares to cover tax obligations. These are standard occurrences and do not indicate a significant positive or negative shift in company fundamentals or executive sentiment beyond the ordinary course of business.

Positives

• The vesting of restricted stock units and stock options aligns executive compensation with company performance and long-term shareholder interests.
• Continued significant direct and indirect beneficial ownership by a key executive demonstrates ongoing commitment to the company.

Negatives

• The disposition of shares to cover tax liabilities, while a routine event, results in a reduction of the executive's direct shareholding.

Future Outlook

The filing indicates future vesting schedules for stock options, with increments expected on February 24, 2026, and February 21, 2027.

Industry Context

NA

Stakeholder Impact

• Shareholders: The transactions are routine and reflect standard executive compensation practices, with no significant direct impact on share price or company strategy. The executive maintains substantial equity ownership, aligning interests.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• Continued vesting of stock options on February 24, 2026, and February 21, 2027.

Key Dates

Recommendation

This Form 4 filing reports routine executive compensation events, specifically the vesting of restricted stock units and the sale of shares to cover tax liabilities. Such transactions are common and generally do not provide new fundamental information that would warrant a change in investment recommendation. The executive maintains substantial beneficial ownership, which is a positive for alignment with shareholder interests.

Keywords

Humana, HUM, Form 4, Insider Transaction, Executive Compensation, Stock Options, Restricted Stock Units, Equity Compensation